How to Regenerate Nerves: Methods and New Research

Peripheral nerves can and do regenerate after injury, though the process is slow and often incomplete. Nerves in the brain and spinal cord face a much harder road, blocked by molecular barriers that peripheral nerves sidestep. The gap between what the body can do on its own and what medicine wants it to do has driven a surge of research into surgical techniques, bioengineered scaffolds, electrical stimulation, gene editing, and stem cell therapies. Some of these approaches are already in clinical use; others remain in animal studies but show enough promise to reshape how nerve injuries are treated in the coming years.

Why Peripheral Nerves Heal and Central Nerves Do Not

The single most important distinction in nerve regeneration is location. Injured peripheral nerves, the ones running through your arms, legs, and trunk, have a built-in capacity to regrow and reconnect with their target muscles or sensory organs.¹ Nerves inside the brain and spinal cord, collectively called the central nervous system, largely lack that ability. Understanding why one succeeds and the other fails is the foundation for every regeneration strategy.

In the peripheral system, a specialized type of cell called a Schwann cell plays the starring role. After a nerve is cut or crushed, Schwann cells transform into what researchers call “repair cells.” They clear away debris from the damaged segment, form tube-like channels that guide regrowing fibers, and release chemical signals that encourage those fibers to extend.² Immune cells assist: macrophages flood the injury site and shift into a clean-up-and-rebuild mode that supports axon regrowth.³ This coordinated response is why a crushed finger nerve can, given time, restore sensation.

The central nervous system tells a different story. When the spinal cord or brain is damaged, a dense scar forms around the injury. That scar is loaded with molecules called chondroitin sulfate proteoglycans, which actively block regrowing nerve fibers from pushing through.⁴ Researchers have shown in lab experiments that blocking a signaling pathway called Rho/ROCK can reduce this inhibition and allow nerve fibers to grow across scar tissue, at least in cell culture and animal models.⁵ But overcoming these barriers in living humans remains one of the great unsolved problems in medicine.

Surgical Repair for Peripheral Nerve Injuries

When a peripheral nerve is severed or a section is lost, surgery is typically the first line of treatment. If the two ends of the nerve can be brought together without tension, a surgeon stitches them directly. When there is a gap, something needs to bridge it. The gold standard for decades has been the autologous nerve graft: a less important sensory nerve is harvested from somewhere else in your body and used to span the gap. This works well because the graft provides a natural scaffold complete with Schwann cells and structural proteins that guide regeneration.⁶

The downsides are real, though. Taking a nerve from one part of the body creates a second wound, sometimes causing numbness, pain, or scarring at the donor site. And there is only so much donor nerve tissue available. These limitations have pushed the development of alternatives. Acellular nerve allografts, processed from donor cadavers with the cellular material removed, offer structural support without requiring a second surgery on the patient. They work reasonably well for smaller gaps, though how they compare to autografts in bridging large defects is still being studied clinically.⁶ Nerve transfer surgery, where a functioning but less critical nerve is rerouted to take over the job of the damaged one, is another increasingly common option, especially for complex injuries like brachial plexus damage.

Bioengineered Nerve Conduits

Rather than relying on donor tissue, researchers have been building synthetic and biological tubes, called nerve guidance conduits, designed to bridge nerve gaps. The basic concept is straightforward: a hollow tube connects the two nerve stumps and gives regrowing fibers a protected channel. But over the past two decades, these devices have become far more sophisticated. Design strategies now include tailored scaffolds made from natural proteins like collagen or synthetic polymers, internal fillers coated with growth-promoting molecules such as laminin and fibronectin, micropatterned surfaces, embedded stem cells, and slow-release packets of growth factors.⁷

One commercially available conduit, NEUROLAC, is made from a polymer called PLCL and has shown results comparable to autografts in some animal studies of motor function recovery. Researchers have further enhanced this type of conduit by immobilizing a neuropeptide called Substance P on its surface, which helps recruit the body’s own stem cells to the injury site and promotes a more regeneration-friendly environment inside the tube.⁸

Three-dimensional printing has opened up new possibilities here. Researchers can now fabricate conduits with precise internal architectures, including grooves and aligned microfibers that physically guide growing nerve fibers in the right direction, much like lanes on a highway. Studies have found that these multi-grooved patterns keep nerve fibers aligned longitudinally, and unidirectional microfibers provide an obstacle-free path for axons, resulting in strong regeneration.⁹ The ability to customize the internal geometry of a conduit to match a specific patient’s injury is one of the more exciting near-term possibilities in this field. Nanoparticle-based platforms are also being explored to deliver drugs, growth factors, and anti-inflammatory agents directly into regenerating nerve tissue, though translating these into approved human treatments still faces hurdles around safety, manufacturing at scale, and regulatory approval.¹⁰

Electrical Stimulation

One of the most clinically accessible methods for boosting nerve regeneration is electrical stimulation. The idea is deceptively simple: applying a brief burst of low-level electrical current to a repaired nerve after surgery can kick-start the regeneration process. Clinical studies have shown that this enhances axon growth and speeds up the recovery of sensation and movement.¹¹ The effect appears to work through several mechanisms, including dampening abnormal pain signaling, improving overall nerve function, and directly accelerating the rate at which nerve fibers extend.¹²

More recently, researchers have combined electrical stimulation with other therapies for stronger effects. In one approach, human neural progenitor cells were seeded inside conductive polymer nerve guides, and the combination of cell therapy plus electrical stimulation outperformed either treatment alone. Animals receiving the combined treatment showed improved sensory and motor function starting just one to two weeks after treatment, along with more regenerated nerve fibers and thicker insulating sheaths around those fibers.¹³ This kind of combination approach, pairing a physical stimulus with biological scaffolding and living cells, represents a trend in the field away from single interventions and toward multimodal treatments.

Photobiomodulation, the use of specific wavelengths of light applied to injured tissue, is a related biophysical approach. Lab studies have shown that it can promote nerve fiber sprouting, stimulate Schwann cell growth, and modify mitochondrial activity in ways that support recovery.¹⁴ It is non-invasive and relatively cheap, which makes it attractive as an add-on therapy, though the clinical evidence in humans is still catching up to the animal data.

Growth Factors and Molecular Therapy

Nerve cells respond to chemical signals called neurotrophic factors, proteins that tell nerve fibers where to grow, how fast to grow, and when to form new connections. Brain-derived neurotrophic factor (BDNF) is among the most studied of these. In a rat model of peripheral nerve injury, researchers showed that continuously releasing BDNF at the repair site over ten weeks caused nerve fibers to grow faster and also reduced neuropathic pain compared to controls.¹⁵ The key word there is “continuous.” A one-time dose does not do much; the growth factor needs to be present over the weeks it takes for nerve fibers to bridge a gap. Much of the engineering work on nerve conduits revolves around solving this delivery problem, creating biodegradable materials that slowly release growth factors at just the right rate.

The challenge of sustained delivery is one reason why gene-based approaches have attracted attention. Rather than loading a scaffold with a protein that gradually runs out, you can reprogram cells at the injury site to produce the growth factor themselves. Researchers used a CRISPR-based activation system to turn on the genes for three neurotrophic factors, including BDNF, GDNF, and NGF, in stem cells derived from fat tissue. These modified cells pumped out elevated levels of all three growth factors for at least three weeks.¹⁶ Wrapping these engineered cell sheets around an injured nerve is a way to create a living, self-sustaining growth-factor factory right where it is needed.

Unlocking Central Nerve Regeneration Through Genetics

The most ambitious frontier in nerve regeneration is getting central nervous system neurons, in the brain, eyes, and spinal cord, to regrow. These neurons have the physical machinery for growth but keep it switched off in adulthood. One breakthrough insight came from studying a gene called PTEN, which acts as a brake on a cellular growth pathway. When researchers deleted PTEN in adult retinal ganglion cells in mice, those cells sent robust new fibers through the optic nerve after injury, something that normally never happens.¹⁷

Since that discovery, PTEN suppression has been tested across several types of central nervous system injury. In mice with spinal cord injuries, deleting PTEN in the neurons whose fibers run through the spinal cord improved forelimb grip strength compared to controls.¹⁸ The same study also flagged a complication: some animals developed late-onset functional abnormalities, a reminder that overriding the body’s growth brakes is not without risk. Suppressing PTEN through various means, including gene knockout, RNA-based knockdown, and drugs, has consistently promoted some degree of axon regrowth in rodent central nervous system injuries.¹⁹

CRISPR technology is now being used to make this approach more precise and potent. Researchers developed a CRISPR/dCas9 system that silences PTEN without actually cutting the DNA, instead adding chemical tags that turn the gene down. In human neural cells derived from induced pluripotent stem cells, this epigenetic approach reduced PTEN expression more effectively than the older RNA-interference method and enhanced nerve fiber outgrowth in cell culture.²⁰ Moving from genetic deletion in lab mice to a controllable epigenetic tool that could theoretically be delivered and later reversed is a meaningful step toward something that might one day be safe enough for humans.

Stem Cells for Spinal Cord Injury

Spinal cord injuries sit at the intersection of the hardest problems in nerve regeneration: central nervous system environment, long distances, complex circuitry. Over the past decade, clinical trials have tested several types of cells, including fetal neural stem cells, stem cells derived from reprogrammed adult cells, mesenchymal stem cells from bone marrow or fat, and olfactory ensheathing cells. Some promising results have emerged, particularly in patients with subacute injuries treated with mesenchymal stem cells, but no treatment has achieved a universally recognized breakthrough.²¹

Olfactory ensheathing cells have generated particular interest because of a biological quirk: they naturally support nerve regeneration in the olfactory system, one of the few places in the adult brain where new nerve connections form throughout life. Transplanting them into injured spinal cords has been tried in human patients, with the rationale that they might carry their pro-regeneration behavior into the hostile central nervous system environment.²² Results in both animals and humans have been variable, and the methods still need improvement and standardization before they can become reliable therapies.²³ Recent work has focused on combining olfactory ensheathing cell transplants with drugs, biomaterial scaffolds, and even gene editing to improve the cells’ survival and integration at the injury site.²⁴

Induced pluripotent stem cells, adult cells reprogrammed back to a flexible state, are increasingly viewed as the next frontier. They can be made from a patient’s own tissue, reducing immune rejection risks, and can be coaxed into becoming virtually any type of neural cell. Early results indicate their potential for future spinal cord therapies, though clinical use is still in its earliest stages.²¹

Exercise and Nerve Healing

For people recovering from peripheral nerve injuries, one of the most accessible interventions is also one of the simplest: physical activity. In rodent studies, voluntary exercise after a nerve crush injury increased the outgrowth of nerve fibers, and the amount of regrowth correlated with the distance the animals ran. The exercised animals also showed higher levels of BDNF, one of the key growth-promoting signals for nerve repair.²⁵ While translating animal wheel-running data directly to human rehabilitation requires some caution, the biological mechanism makes sense: exercise boosts the body’s production of growth factors that nerve cells depend on. This is why structured physical therapy is a standard part of nerve injury recovery, not just to prevent muscle wasting while waiting for nerves to regrow, but because it may genuinely speed the regrowth itself.

Tracking Regeneration With Imaging

One longstanding frustration in treating nerve injuries is that you often cannot tell how well regeneration is progressing without invasive testing or simply waiting to see if function returns. Diffusion tensor imaging, an MRI-based technique, is changing that. It works by tracking the movement of water molecules along nerve fiber tracts, producing detailed maps of nerve structure that can reveal whether fibers are regenerating and how far they have extended.²⁶ Researchers have demonstrated that the technique can successfully visualize even the terminal branches of complex nerve networks like the brachial plexus, the large nerve bundle that controls the arm, in a highly reproducible way.²⁷ For clinicians, this means being able to monitor a patient’s nerve recovery non-invasively over time, which could help decide whether a surgical revision is needed or whether a nerve graft is integrating properly.

What Zebrafish Reveal About Nerve Repair

If you want to understand what unrestrained nerve regeneration looks like, the zebrafish is the organism to study. After spinal cord injury, adult zebrafish activate resident neural progenitor cells, which proliferate and differentiate into new neurons that integrate into the existing spinal circuitry. The response is so robust that some neuron types are produced in dramatic excess: serotonergic neurons, for example, increase to about five times their normal numbers after injury, and motor neurons are generated beyond what the cord ultimately retains.²⁸ Mammals share many of the same genes and signaling pathways but keep them locked down after development. Much of the genetic work on PTEN and growth pathways described earlier is essentially trying to reawaken in mammals some of the regenerative capacity that fish and amphibians never lose.

Magnetic Nanoparticles and Directed Growth

Among the more inventive approaches to nerve regeneration is the use of magnetic nanoparticles to physically steer growing nerve fibers. The concept works like this: tiny magnetic particles are introduced into nerve cells, and an external magnetic field is applied to generate a gentle pulling force on the cell in a specific direction. In experiments with neuron-like cells, this technique shifted the direction of nerve fiber outgrowth by about 30 degrees toward the direction imposed by the magnetic field.²⁹ The appeal is that it is entirely non-invasive once the nanoparticles are in place. You could theoretically guide regenerating fibers through complex tissue without additional surgery, using external magnets to set the direction. The technology is still early-stage, but it illustrates how creative the field has become in combining physics, materials science, and biology to solve what was once considered an intractable problem.